The Global Health Body Issues Concern Over Severe Scarcity of Obesity Injections
Less than one in 10 people that would benefit from obesity jabs such as Wegovy are able to get them, states the World Health Organization as it releases its first advice on the medications.
Considering more than one billion people worldwide now obese, it is urging increased and just access to these injectable treatments.
According to estimates, in excess of 2,000,000,000 are projected to be living with obesity by 2030 without intervention.
"Our new guidelines acknowledges that excess weight is a chronic disease that can be managed with holistic and continuous treatment," said WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and supply-chain constraints are major obstacles to broad availability to the injections that can help people shift significant weight, explains the agency.
Skinny Jab Scarcity
Even under the current best projected outlook, the supply of these medications might only reach about 100 million people – under 10% of the global need, according to the WHO.
The recommendation urges countries and companies to increase access, by strategies like licensing agreements.
The intellectual property rights on a key compound – the core component of the drug Wegovy – is due to expire in a number of countries in 2026.
How Obesity Jabs Function
The injections replicate a body's own hormone to slow digestion, curb appetite and enhance the sense of being full so users consume fewer calories.
Individuals typically begin shedding pounds in the initial weeks of starting on the once-weekly jabs.
Studies indicates users may put most of the weight back on after a year of halting the treatment, when their typical hunger come back.
To be above a healthy weight raises your chance for contracting health problems, such as type 2 diabetes, heart disease, brain attack, and some malignancies.
Obesity affects individuals in countries worldwide and was associated with over three and a half million deaths worldwide in 2024, according to the health agency.
